Welcome

Welcome to the 'Oxford Innovative Organic Synthesis for Cancer Research (OxIOSCR)' project, an EU-funded Marie Curie Innovative Doctoral Programme (IDP), established to train graduate organic chemists to develop synthetic routes to natural products and their analogues with potent anti-cancer activity.
Stacks Image 126
Thirteen doctoral research students, Early Stage Researchers (ESRs), have undertaken a three-year comprehensive training programme, working within the Department of Chemistry at the University of Oxford, using state-of-the-art synthetic methods and techniques with a particular focus on biocatalysis, electrosynthesis and flow chemistry. The ESRs worked in teams of three or four on distinct programmes of research supported by expert chemistry and cancer biology advisers. Although largely based within Oxford's research environment, the ESRs, during their second year of training, were posted on two one-month secondments hosted by eight Associated Partners distributed over six European countries.

Stacks Image 5544
The overarching aim of the OxIOSCR training programme is to lead to more sustainable synthetic chemistry, new strategies for organic synthesis, a strongly connected network of chemists and cancer biologists and release a generation of fully trained synthesis innovators into the academic and chemical industrial workplace.

Recent highlights

Thesis submission (2nd Oct 2017): Well done to Christian Kuper who handed in his thesis on 2nd October 2017. Read more…
Thesis submissions (29 Sept 2017): Well done Patricia and Philipp for the submission of their DPhil thesis on 29th Sept 2017. Read more...
Congratulations (Sept 2017): Well done to Sandra Balcells Garcia for the submission of her DPhil thesis (25th Sept 2017). Read more…
Publication (Sept 2017). Well done to Allegra Franchino on her publication in RSC Advances. Read more…
Stacks Image 1536
This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement number: 316955.